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Key points
• Cystic fibrosis (CF) is a lethal disease characterized by low rates of epithelial Cl− and HCO3−
secretion and obstruction of the airways and gastrointestinal and reproductive organs by sticky
mucus. HCO3− secretion has recently been demonstrated to be necessary formucus hydration.
• The most frequent CF mutation is F508del. This mutant protein is usually degraded in the
proteasome. New therapeutic strategies have been developed which deliver F508del to the
plasma membrane.
• Utilizing transgenic F508del mutant and cystic fibrosis transmembrane conductance regulator
(CFTR) knockout mice, apical membrane expression of F508del protein was found to be
associated with enhanced stimulation of intestinal HCO3− secretion.
• The predominant molecular mechanism for enhanced F508del HCO3− stimulation appeared
to be the activation of a Cl− recycling pathway, with Cl− exit via membrane-resident F508del
protein and Cl− entry in exchange for HCO3− by apical Cl−/HCO3− exchange. In contrast,
the predominant molecular mechanism for cAMP-activated HCO3− secretion inWT intestine
appears to be HCO3− exit via CFTR itself.
Abstract This study investigated whether expression of the common cystic fibrosis trans-
membrane conductance regulator (CFTR)mutant F508del in the apicalmembrane of enterocytes
confers increased bicarbonate secretory capacity on the intestinal epithelium of F508del mutant
mice compared to that of CFTR knockout (KO) mice. CFTR KO mice, F508del mutant mice
(F508del) and wild-type (WT) littermates were bred on the FVB/N background. F508del iso-
lated brush border membrane (BBM) contained approximately 5–10% fully glycosylated band
C protein compared to WT BBM. Similarly, the forskolin (FSK)-induced, CFTR-dependent
short-circuit current (I sc) of F508del mucosa was approximately 5–10% of WT, whereas
the HCO3− secretory response (J HCO −3 ) was almost half that of WT in both duodenum
and mid-colon studied in vitro and in vivo. While WT intestine retained full FSK-induced
J HCO −3 in the absence of luminal Cl
−, the markedly higher J HCO −3 than I sc in F508del
intestine was dependent on the presence of luminal Cl−, and was blocked by CFTR inhibitors.
The Ste20-related proline–alanine-rich kinases (SPAK/OSR1), which are downstream of the
with-no-lysine (K) protein kinases (WNK), were rapidly phosphorylated by FSK in WT and
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F508del, but significantly more slowly in CFTRKO intestine. In conclusion, the data demonstrate
that low levels of F508del membrane expression in the intestine of F508del mice significantly
increased FSK-induced HCO3− secretion mediated by Cl−/HCO3− exchange. However, in WT
mucosa FSK elicited strong SPAK/OSR1 phosphorylation and Cl−-independent HCO3− efflux.
This suggests that therapeutic strategies which deliver F508del to the apical membrane have the
potential to significantly enhance epithelial HCO3− secretion.
(Received 27 March 2012; accepted after revision 12 July 2012; first published online 16 July 2012)
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Introduction
Cystic fibrosis (CF) epithelia display a reduction in
Cl−, HCO3− and fluid secretion and an increase in salt
and fluid absorption (Greger et al. 2001; Seidler et al.
2009; Quinton, 2010). The pathophysiological correlates
are sticky, viscous mucoid secretions impacting ductal
structures of multiple glandular organs and the intestine,
which result in progressive glandular destruction, and
increased susceptibility to bacterial infections in the
respiratory airways (Quinton, 2010). Recent data suggest
that epithelial HCO3− secretion may be required for the
release, as well as the rheological properties, of intestinal,
airway and reproductive tract mucins (Garcia et al. 2009;
Chen et al. 2010; Muchekehu & Quinton, 2010), and thus
be of great pathophysiological relevance.
The molecular mechanisms of epithelial HCO3−
secretion are complex and involve both different anion
channels and Cl−/HCO3− exchangers. Likewise, the
molecular correlate for defective HCO3− secretion
in cystic fibrosis transmembrane conductance
regulator (CFTR)-deficient or CFTR mutant epithelia is
controversial, but recent data point to the involvement
of various transporters in different CFTR-expressing
epithelia (Steward et al. 2005; Dorwart et al. 2008; Seidler
et al. 2009; Beuers et al. 2010; Quinton, 2010). While
evidence has accumulated over the last two decades that
the CFTR anion channel may become permeable to
HCO3− under certain conditions (Poulsen et al. 1994,
Clarke et al. 1998, Spiegel et al. 2003; Shcheynikov et al.
2004; Ishiguro et al. 2009; Park et al. 2010), it is also clear
that anion exchangers from the Slc26 family are involved
in epithelial HCO3− secretion (Steward et al. 2005; Tuo
et al. 2006; Dorwart et al. 2008; Walker et al. 2009). A
recent study suggests that the activation of the with no
lysine (WNK) protein kinases 1 and 4–Ste20-related
proline–alanine-rich kinases (SPAK/OSR1) signalling
pathway in response to a decrease in intracellular Cl−
concentration in pancreatic duct cells may result in a
change of the anion selectivity of CFTR from Cl− to
HCO3− predominance and in an inhibition of apical
Cl−/HCO3− exchangers (Park et al. 2010). On the other
hand, CFTR and members of the Slc26 family have been
shown to structurally interact, at least in heterologous
expression systems, with reciprocal activation of their
individual transport functions (Ko et al. 2004). Thus, two
fundamentally different potential mechanisms exist for
CFTR-mediated epithelial HCO3− secretion, and both
may be operative in different epithelia under distinct
physiological conditions.
Themost frequentmutation in CF patients, the F508del
mutation, is the deletion of a phenylalanine residue
at position 508 of the CFTR amino acid sequence.
Early studies on the biosynthesis and localization of
F508del-CFTR indicated that the mutant protein is not
folded correctly and, as a result, is not delivered to the
plasma membrane (Cheng et al. 1990, Gregory et al.
1991; Ward & Kopito, 1994). Premature degradation of
F508del-CFTR can be partially inhibited by reducing
the temperature of cultured cells or isolated tissue
to 26◦C (‘temperature rescue’), leading to increased
F508del-CFTR membrane expression (Denning et al.
1992). But even when F508del-CFTR reaches the plasma
membrane, it is prematurely degraded (Lukacs et al.
1993; Okiyoneda et al. 2010) and displays defective anion
transport (Dalemans et al. 1991; Wang et al. 2000; Tang
et al. 2009). However, novel drug treatment strategies
have recently been developed that directly target the
molecular defects inCFpatients, including substances that
partially prevent the degradation of mutant CFTR in the
proteasome and result in improved membrane expression
and increased Cl− transport by epithelial cells (Lukacs &
Verkman, 2012).
We wondered if F508del-CFTR membrane expression
might restore epithelial HCO3− secretion. To address
this question, we utilized the F508del-CFTR mouse on
the FVB/N background, in which some F508del-CFTR
protein reaches the small intestinal brush border
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membrane (BBM), anda residual forskolin (FSK)-induced
short-circuit current (I sc) is measured (French et al.
1996). We determined the amount of mature, fully
glycosylated (band C) CFTR protein in the BBM of
wild-type (WT) and F508del intestine, measured basal
and FSK-induced HCO3− secretion in the duodenum and
colon of WT, F508del and CFTR KO mice in vivo and in
vitro, and assessed the transportmechanism(s) involved in
F508del-augmented HCO3− secretion. Finally, we studied
(i) whether SPAK/OSR1 phosphorylation may occur
during agonist stimulation of intestinal anion secretion in
vivo, (ii) if this pathway may be defective in the absence of
CFTR expression, (iii) whether F508del-CFTR expression
at the apical membrane restores WNK signalling, and (iv)
if this pathway explains the differential dependence of
CFTR-mediated epithelial HCO3− secretion on luminal
Cl− in different experimental systems.
Methods
Animals
TheCFTRKOmouse strainwas originally generated in the
laboratory of Martin Evans (Ratcliff et al. 1993) and the
F508del-mutant strain in the laboratory of Bob Scholte
(French et al. 1996). Both CFTR KO and F508del mice
were congenic on the FVB/N background. Mice were bred
at the animal care facility of Hannover Medical School
under standard temperature and light conditions, and
were allowed free access to food and water. The mice
received electrolyte drinking solution containing poly-
ethylene glycol (PEG) and high HCO3− (in mM: 40
Na2SO4, 75 NaHCO3, 10 NaCl, 10 KCl, 23 g l−1 PEG
4000), and a fibre-free diet (Altromin, C1013) to allow
survival beyond weaning. Care was taken to match the
mice not only as sex-matched littermates but also in terms
of an equal number of weight-matched male and female
pairs in each group of experiments. WT refers to the
+/+ littermates of the respective strain. All experiments
involving animals were approved by the Hannover
Medical School Committee on investigations involving
animals and an independent committee assembled by
the local authorities (Niedersa¨chsisches Landesamt fu¨r
Verbraucherschutz und Lebensmittelsicherheit).
pH-stat titration of HCO3− secretory rates in isolated
duodenal and mid-colonic mucosa
Ussing chamber experiments were performed as described
previously (Seidler et al. 1997) in the open-circuit mode,
with intermittent current pulses (200μA every 60 s) to
record the electrical resistance (Rt), and to calculate
a nominal short-circuit current (I sc). Mice were sub-
jected to brief CO2 narcosis prior to cervical dislocation
before excising intestine for isolatedmucosa preparations.
The excised duodenum and mid-colon were stripped of
external muscle layers and mounted in Ussing chambers
(0.625 cm2 aperture). Neural activity and prostaglandin
generation were blocked with tetrodotoxin (1μM, serosal)
and indomethacin (3μM, serosal), respectively. Trans-
epithelial I sc was calculated as μEq cm−2 tissue surface
area. The serosal solution contained (in mM): 108 NaCl,
25 NaHCO3, 3 KCl, 1.3 MgSO4, 2 CaCl2, 2.25 KH2PO4,
8.9 glucose, and 10 sodium pyruvate, and was gassed with
95%O2–5%CO2 (pH7.4). Themucosal solution (154mM
NaCl or 154mM sodium gluconate) was gassed with 100%
O2.
Surgical procedure: ‘in vivo duodenal/colonic loop
experiment’
Micewere anaesthetized by spontaneous inhalation of iso-
flurane (Forene; Abbott Germany, Wiesbaden, Germany)
and experiments performed as previously described
(Sjoblom et al. 2009). In brief, a catheter was placed
in the left carotid artery for continuous infusion of
(in mM: 200 Na+, 100 CO32−, 5 K+ and 5 Cl−) at
a rate of 0.30 ml h−1 to correct the systemic acid–base
balance in isoflurane-anaesthetizedmice.After ligating the
pancreatic and biliary ducts, about 1 cm of the proximal
duodenum was perfused for the experiments. A small
polyethylene tube (PE100; polyethylene, inner diameter
1 mm) with a distal flange was advanced to the duodenal
bulb, and secured by a ligature, and another PE200 (poly-
ethylene; inner diameter 2 mm) flanged tube was secured
in the distal end of the perfused segment by ligature to
allow fluid drainage. A similar procedure was performed
in the colon, with the input tube 2–2.5 cm distal to the
caecocolonic junction and the exit tube approximately
2 cm proximal to the anus. The isolated segments with an
intact blood supply were gently flushed and then perfused
(Perfusor compact; Braun) at a rate of 15ml h−1 with
154mM NaCl. Effluents from the isolated segment were
visually free of bile and blood throughout all experiments.
Animals were maintained at 37◦C using a heating pad
controlled by a rectal thermistor probe. Mice were killed
at the end of the experiment by cervical dislocation while
still under anaesthesia.
Measurement of duodenal or colonic HCO3− secretion
in vivo
The rate of luminal alkalinization was determined by back
titration of the perfusate to pH 5.0 with 2mM HCl by
use of pH-stat equipment (PHM82 Standard pH meter,
Radiometer, Copenhagen, Denmark) as described (Singh
et al. 2008). HCO3− production was determined for each
10min period and rates of luminal alkalinization are
C© 2012 The Authors. The Journal of Physiology C© 2012 The Physiological Society
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expressed as micromoles of base secreted per centimetre
of intestine per hour (μmol cm−1 h−1).
Intestinal brush border membrane preparation and
Western blot analysis
All processes were done at 4◦C. After thoroughly
rinsing with phosphate-buffered saline (PBS), intestinal
segments were cut open longitudinally, the mucosa
scraped with a glass slide, and mucosal scrapings
suspended in 2ml of buffer A (270mM mannitol, 12 mM
Tris, 16 mM Hepes, 1 mM EGTA, 1.006mM CaCl2, pH
7.4, 40μgml−1 phenylmethylsulfonyl fluoride (PMSF),
20μgml−1 leupeptin, 20μgml−1 pepstatin A, 20μgml−1
antipain, 1 mM dithiothreitol (DTT), 4 mM benzamidine)
and homogenized gently by thorough pottering (at least
20 up and down strokes with a rotating potter (Potter
S, Braun Melsungen, Germany), 1100 Umin−1 rotating
speed). The volume was made up to 12ml with buffer A
and the homogenate was centrifuged at 2000 g for 10min.
The supernatant was collected and 1 M MgCl2 added to
a final concentration of 10mM with 15min of mixing
before centrifuging at 3000 g for 15min. Then, the super-
natant was centrifuged at 30,000 g for 30min. The pellet
was suspended in buffer B (270mM mannitol, 12 mM
Tris, 16 mM Hepes, pH 7.4, 40μgml−1 PMSF, 20μgml−1
leupeptin, 20μgml−1 pepstatin A, 20μgml−1 antipain,
1 mM DTT, 4mM benzamidine) and the MgCl2 pre-
cipitation and centrifugation steps repeated. The super-
natant was centrifuged at 30,000 g for 30min. The pellet
was resuspended in TN buffer (50mM Tris-Cl, 150mM
NaCl, pH 7.4, 40μgml−1 PMSF, 20μgml−1 leupeptin,
20μgml−1 pepstatin A, 20μgml−1 antipain, 1 mM DTT,
4mM benzamidine) and homogenized using a 25G needle
to produce the brush border membrane (BBM) fraction
used for SDS-PAGE. One hundred micrograms of BBM
was denatured in sample buffer at 65◦C for 10min
and resolved on a 10% SDS-polyacrylamide gel, trans-
ferred to PVDFmembrane (GE Healthcare Life Sciences).
Blots were blocked with 5% skimmed milk and first
incubated with rat anti-CFTR (3G11 kindly provided
by the CFTR Consortium; 1:500, http://cftrfolding.org/,
generated against the first nucleotide binding domain)
or rabbit anti-β-actin antibody (Abcam, Cambridge,
MA, USA;1:10,000) overnight at 4◦C followed by horse-
radish peroxidase (HRP)-conjugated anti-rat antibody
(KPL; 1:5,000, KPL Inc. Gaithersburg, Maryland, USA)
or anti-rabbit antibody (KPL; 1:10,000) for 1 h at
room temperature. Blots were developed using ECL (GE
Healthcare Life Sciences).
Assessment of SPAK phosphorylation in vivo
In vivo perfusion was performed as described above. Mice
in the control groups were luminally perfused with iso-
tonic saline for 40min. The experimental groups of mice
were perfused with saline for 20min, followed by either
isotonic sodium gluconate or saline containing 10μM
FSK. After killing, the perfused segment was excised, and
the mucosa scraped, homogenized, lysed in SDS buffer,
heated at 95◦C for 5min, centrifuged at 15,000 rpm for
15min to remove cellular debris, and stored at −80◦C
until further use. Western analysis was performed as
described above, using rabbit anti-SPAK (Cell Signaling
Technology, Inc., Danvers, MA, USA, no. 2281; 1:500),
rabbit anti-β-actin antibody (Abcam; 1:10,000) and rabbit
anti-pSPAK/anti-pOSR1 (1:5000).
Reagents
Tetrodotoxin was purchased from Biotrend Chemicals
AG (Wangen, Switzerland), forskolin from Alexis
Biochemicals (Lo¨rrach, Germany), and other reagents
from Sigma-Aldrich (Deisenhofen, Germany), or the
suppliers given in the text. GlyH-101 was a kind gift of
Alan Verkman (University of California San Francisco).
Statistics
All resultswere expressed as themean± SEM. ‘J HCO −3 ’ and
‘I sc’ represent the mean value of basal HCO3− secretion
and I sc, respectively, in either luminal NaCl or sodium
gluconate in the 3–5minbefore the administrationof FSK.
‘J HCO −3 ’ and ‘I sc’ represent, for each experiment, the
maximal response after the secretagogue averaged over
3–5min minus the basal value (i.e. the net stimulated
murine HCO3− secretion or I sc). Because the time course
of stimulationmay differ fromone experiment to the next,
and because secretory rates may decline after a maximal
response, the maximal value of the averaged time courses
may differ from the calculated J HCO −3 or the I sc values
in the bar graphs. Data were analysed by Student’s t test
for paired samples or by ANOVAwith post hoc analysis for
multiple comparisons. P < 0.05 was considered to denote
statistical significance.
Results
Western blot analysis of CFTR protein
Western blot analysis of highly purified murine small
intestinal BBM revealed that the amount of mature
fully glycosylated band C protein in F508del BBM was
approximately 5–10%of that found inWTBBM(Fig. 1A);
no band C was detected in CFTR KO BBM (Fig. 1B).
Figure 1 displays representative Western blots of pooled
BBM from three mice in each group. The experiment was
repeated several times with similar results. However, due
to weak expression of mature fully glycosylated F508del
C© 2012 The Authors. The Journal of Physiology C© 2012 The Physiological Society
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protein, maximal loading of the gel with protein (100μg)
was necessary for its detection, which caused the bands for
the loading controls (β-actin, villin) to become saturated
evenwith very short exposure times. Precise quantification
and comparison of bandC betweenWT and F508del BBM
was therefore not attempted.
Basal HCO3− secretion (J HCO −3 ), HCO3
− secretory
response to forskolin (FSK) (J HCO −3 ), basal Isc,
FSK-induced Isc, and tissue resistance in F508del,
CFTR KO and WT duodenal mucosa in vitro
The basal HCO3− secretory rate (J HCO −3 ) was not
significantly different in isolated duodenal mucosa from
WT and F508del, but was reduced in CFTR KO mucosa
Figure 1. Western blot analysis of isolated brush border
membranes (BBM) for CFTR expression
A, analysis of highly enriched small intestinal BBM from WT and
F508del littermates, probed with an anti-CFTR antibody. The F508del
BBM showed ∼7% of the band C concentration seen in the WT
(left). Exact quantitation was not possible because maximal loading
of gels with protein (100 μg) was necessary to make the faint band
visible; this amount of protein caused the β-actin band to saturate.
Interestingly, there is also some band B present in the BBM. This may
represent alternative trafficking of CFTR to the BBM. B, in CFTR KO
mice, no band B or band C was detected. Pooled BBM from 3
different mice was used for each lane. In each lane 100 μg protein
was loaded.
(inμmol cm−2 h−1:WT: 1.41± 0.12, F508del: 1.17± 0.28
andCFTRKO: 1.00± 0.22,P < 0.05, Fig. 2A). In contrast,
the FSK-stimulatedHCO3− secretory response (J HCO −3 )
was significantly higher in F508del duodenum than in
CFTR KO duodenum, but significantly lower than that in
WT mucosa (Fig. 2A and C).
Calculated basal I sc was less negative (even slightly
positive) in F508del and CFTR KO duodenum compared
to WT (in μEq cm−2: F508del: 0.15± 0.27 and CFTR
KO: 0.68± 0.27 vs. WT: −0.65± 0.32, P < 0.05, Fig. 2B),
indicating a virtual lackofCFTR-mediated anion secretion
in the basal state in the former epithelia, but sub-
stantial spontaneousCFTRactivity inWTmucosa, despite
chemical denervation and inhibition of endogenous
prostaglandin synthesis. Furthermore an FSK-induced I sc
response (I sc) was not significantly different from zero
in CFTRKOduodenum, whereas there was a smallI sc in
F508del duodenal mucosa and a much greater one in WT
mucosa (Fig. 2B and D). Tissue resistance Rt was highest
in CFTR KO duodenal mucosa in the basal state (Fig. 2E),
whereas a transient FSK-induced increase inRt (which has
been attributed to a collapse of the lateral spaces during
secretion (Gawenis et al. 2004) was observed only in WT
mucosa.
Because the F508del mutant has a gating defect in
addition to reduced membrane stability (Dalemans et al.
1991), we added the CFTR potentiator genistein (10μM)
together with FSK, to isolated duodenal mucosa of
F508del mutant and WT littermates (Yang et al. 2003,
Yu et al. 2011). The subsequent FSK+genistein-induced
J HCO −3 was higher than the FSK-induced J HCO −3 by
an absolute rate of 0.40± 0.08μEq cm−2 (ns), while
the FSK+genistein-induced J HCO −3 in the WT mucosa
was enhanced to a similar degree (Suppl. Fig. 1).
Given the fact that the effects of genistein and FSK on
F508del-induced I sc were not more pronounced than
on WT I sc, and that genistein may act through multiple
mechanisms to activate CFTR (Tuo et al. 2009, 2011), this
line of experiments was not pursued further. However,
the experiments show that a combination of agonists
stimulate HCO3− secretion in F508del intestinal mucosa
even further than a maximal concentration of a cAMP
agonist.
J HCO −3 , Isc and tissue resistance in F508del, CFTR
KO and WT mid-colonic mucosa in vitro
The next question to address was whether a HCO3−
secretory response to FSK was also seen in the colon of
F508del mice. Murine colon displays very low J HCO −3
in the proximal segment, due to high NHE3 and low
DRA (Slc26a3) BBM expression (Talbot & Lytle, 2010;
Xiao et al. 2012), but high J HCO −3 in the mid- and distal
colon (Xiao et al. 2012). We therefore used the mid-colon
C© 2012 The Authors. The Journal of Physiology C© 2012 The Physiological Society
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(starting 2 cm after the caecocolonic junction and ending
approximately 2 cm proximal to the anus) for our studies.
Figure 3A shows the high basal J HCO −3 of mid-colonic
mucosa for all three genotypes (in μmol cm−2 h−1:
WT: 4.45± 0.19, F508del: 4.35± 0.36 and CFTR KO:
3.60± 0.40) with a further significant increase after
FSK application. Although the time course of J HCO −3
increase after FSK was significantly slower in F508del
than WT mucosa, the J HCO −3 was not different 30min
after FSK addition in the F508del and WT mucosa,
but was significantly lower in the CFTR KO colonic
mucosa (Fig. 3A,P < 0.05).However, the relativeJ HCO −3
response expressed as a percentage of the basal rate
was not significantly different in the three genotypes
(Fig. 3B).
Basal I sc was markedly more negative in WT compared
to F508del and CFTR KO mid-colonic mucosa (in
μEq cm−2: WT: −5.20± 0.73, F508del: −1.03± 0.35 and
CFTR KO: −1.93± 0.30), suggesting CFTR-mediated
electrogenic anion secretion despite the presence of
indomethacin and TTX (Fig. 3C, P < 0.001). FSK elicited
a strong I sc in WT mucosa, a small I sc in F508del
mucosa, and no response in CFTR KO mucosa (Fig. 3B
and D). Thus, although we could not directly quantify
the F508del CFTR mutant protein in the colonic BBM
(less mucosa and fewer enrichment factors for colonic vs.
small intestinal BBM prevented unequivocal detection of
the mutant protein in colonic preparations), functional
evidence for F508del membrane expression was obtained
in the colonic mucosa of F508del mice similar to results in
the small intestine.
The tissue resistance of colonic mucosa was larger than
that of duodenal mucosa, and was not different between
the three genotypes (Fig. 3E). It decreased rapidly upon
FSK stimulation in the WT mucosa, consistent with the
opening of an apical conductance in a relatively ‘tight’
Figure 2. Basal and FSK-stimulated J HCO −3
, Isc and resistance (Rt) in duodenal mucosa
Time course of JHCO −3
(A), Isc (B) and Rt (E) in duodenal mucosa. C and D, FSK (10−5 M)) -induced JHCO −3and Isc in duodenal mucosa of the three different genotypes. FSK-induced Isc was highly significantly different
between WT and the two CF genotypes, as well as different between F508del and CFTR KO duodenum. See text
for further information about basal Isc. ∗∗∗P < 0.001, ∗∗P < 0.01, ∗P < 0.05; ns, no statistical difference; n = 5–11.
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epithelium, and very slowly and to an overall lesser degree
in the other genotypes.
J HCO −3 and FSK-induced J HCO −3 across F508del, CFTR
KO and WT duodenum and colon in vivo
We next measured J HCO −3 in luminally perfused
duodenum andmid-colon before and after FSK perfusion
in anaesthetized mice. In the duodenum, basal J HCO −3
prior to FSK stimulation was significantly lower in
CFTR KO compared to WT and F508del mucosa (in
μmol cm−1 h−1: WT: 5.26± 0.54, F508del: 5.10± 0.58
and CFTR KO: 3.97± 0.32, Fig. 4A, P < 0.05), whereas
WT and F508delmucosa were not statistically different. In
contrast, FSK-stimulatedJ HCO −3 was significantly higher
in F508del duodenum than in CFTR KO duodenum, but
significantly lower than in WT (Fig. 4A and B).
Figure 4C shows the high J HCO −3 in the mid-colonic
mucosa of all three genotypes in vivo (in μmol cm−1 h−1:
WT: 9.58± 0.48, F508del: 8.56± 0.90 and CFTR KO:
7.82± 0.64), with a further significant increase after FSK
application (Fig. 4C and D). Again, the FSK-induced
J HCO −3 in F508del mid-colon was significantly higher
than that in CFTR KO colon, but significantly lower than
in WT colon.
Effect of luminal Cl− on FSK-induced J HCO −3 , Isc
and Rt in WT, F508del and CFTR KO duodenal mucosa
We next explored the potential involvement of apical
Cl−/HCO3− exchangers in the elevated HCO3− secretion
by F508del duodenal mucosa. Replacement of Cl− with
gluconate in the luminal bath significantly reduced basal
J HCO −3 similarly in all three genotypes (inμmol cm
−2 h−1:
Figure 3. Basal and FSK-stimulated J HCO −3
, Isc and resistance (Rt) in mid-colonic mucosa
Effects of FSK (10−5 M) on the time course of JHCO −3
(A), Isc (B) and Rt (E) in isolated mid-colonic mucosa. C and D,
individual secretory responses in JHCO −3
and Isc, for the three different genotypes. In mid-colonic mucosa, the
absolute magnitude of FSK-induced JHCO −3
was not significantly different between each genotype. FSK-induced
Isc was highly significantly different between WT and the two CF genotypes. See text for further information
about basal Isc. ∗∗∗P < 0.001; ns, no statistical difference; n = 5–11.
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WT: 1.17± 0.25 to 0.76± 0.20, F508del: 0.87± 0.16 to
0.52± 0.20 and CFTR KO: 0.94± 0.12 to 0.69± 0.15,
P < 0.05) (Fig. 5A). Subsequent stimulation by FSK in
the absence of luminal Cl− did not significantly reduce
J HCO −3 in WT mucosa compared to that in the pre-
sence of luminal Cl− (see Figs 2C and Fig. 5C), but
abolished the difference in J HCO −3 between F508del
and CFTR KO mucosa (Fig. 5C). This suggests that the
HCO3− secretory response in theF508delmucosa is largely
mediated by luminal Cl−/HCO3− exchange, whereas the
WT duodenum is capable of Cl−-independent HCO3−
secretion.
The basal I sc of CFTR KO duodenal mucosa in
the presence of luminal Cl− was significantly less
negative than in F508del and WT mucosa (in μEq cm−2:
CFTR KO: 0.19± 0.33, F508del: −0.41± 0.17 and WT:
−0.52± 0.23, P < 0.05) (Fig. 5B), but increased to similar
values after the removal of luminal Cl− (in μEq cm−2:
WT: −1.89± 0.38, F508del: −2.06± 0.73 and CFTR KO:
−1.87± 0.38) (Fig. 5C), demonstrating that the increase
in I sc after luminal Cl− removal is not primarily due to
an increased electrochemical gradient for CFTR-mediated
Cl− efflux, but may be a diffusion potential elicited by
the charge selectivity of tight junctions. The subsequent
FSK-induced I sc did not differ significantly compared
to the I sc in the presence of luminal Cl− and was
significantly higher in WT than the other two genotypes
(Figs 2D and 5D).
Tissue resistance (Rt) increased significantly upon
luminalCl− removal to similar levels in all three genotypes,
and the subsequent transient increase in Rt in response to
FSKwas even slightly enhanced in theWT tissue compared
to Cl− containing solutions (Figs 2E and 5E).
Effect of luminal Cl− on FSK-induced J HCO −3 , Isc
and Rt in WT, F508del and CFTR KO colonic mucosa
In mid-colonic mucosa, the substitution of luminal
Cl− with gluconate resulted in a dramatic decrease
in basal J HCO −3 in all three genotypes, consistent
with high rates of luminal alkalinization mediated
by apical Cl−/HCO3− exchange (in μmol cm−2 h−1:
WT: 4.00± 0.28 to 1.61± 0.16, F508del: 3.90± 0.22 to
1.34± 0.16 and CFTR KO: 4.13± 0.35 to 1.28± 0.17)
(Fig. 6A). These high luminal alkalinization rates are not
dependent on CFTR expression, since both J HCO −3 and
the decrease in J HCO −3 after removal of luminal Cl
− were
Figure 4. Basal and FSK-stimulated duodenal and
mid-colonic HCO3− secretion (J HCO −3 ) inanaesthetized mice
Time course (A and C) and magnitude of HCO3−
secretory response (B and D) in luminally perfused
duodenum (A and B) and mid-colon (C and D) of
anaesthetized WT, F508del and CFTR KO mice.
FSK-induced JHCO −3
was significantly different in
luminally perfused duodenum and mid-colon between
each genotype. ∗P < 0.05; n = 5.
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identical in all three genotypes. Cl− removal did not
significantly influence subsequent FSK-induced J HCO −3
responses in eitherWT or CFTR KOmucosa, but strongly
reduced J HCO −3 in the F508del mucosa to that seen
in CFTR KO mucosa (Figs 3A and C and 6A and C).
This suggests that similar to duodendal mucosa, F508del
expression in mid-colonic mucosa elicits an FSK-induced
increase in Cl−/HCO3− exchange.
Luminal Cl− removal resulted in a strong I sc
increase in colonic mucosa from all three genotypes
(in μEq cm−2: WT: −3.01± 0.57 to −5.27± 0.63,
F508del: −0.65± 0.20 to −2.85± 0.46 and CFTR KO:
−0.78± 0.34 to −2.97± 0.34, P < 0.01) (Fig. 6B). Sub-
sequent FSK-elicitedI sc was less negative in all genotypes
than in the presence of luminal Cl− (Figs 3D and 6D).
Tissue resistance (Rt) increased significantly upon
luminal Cl− removal in all three genotypes and FSK
application resulted in a small decrease in Rt in all three
genotypes (ns) (Fig. 6E).
NHE3 inhibition abolished the FSK-mediated small
increase in luminal alkalinisation in CFTR KO mucosa
In CFTR KO duodenal as well as mid-colonic mucosa,
FSK application generated a small, but significant,
J HCO −3 without any change in I sc, suggesting that this
J HCO −3 response is unlikely to be mediated by an anion
conductance (Figs 2 and 3). Inhibition of the apical
Na+/H+ exchanger NHE3 increases duodenal HCO3−
Figure 5. Luminal Cl− removal abolished the augmentation of FSK-induced J HCO −3 by F508del-CFTRmembrane expression in duodenal mucosa
Replacement of Cl− in the luminal bath by gluconate caused a slight decrease in the basal JHCO −3
in each
genotype (A), and reduced the JHCO −3
in the F508del mucosa to the JHCO −3
values seen in the
CFTR KO mucosa (A and C). These data suggest that FSK (10−5 M) elicits a robust JHCO −3
independently
of luminal Cl−/HCO3− exchange in WT mucosa, whereas the augmentation of FSK-induced JHCO −3
by F508del
expression requires luminal Cl−/HCO3− exchange. Basal Isc (B) and Rt (E) increased significantly in all three
genotypes after Cl− replacement by gluconate, and the Isc response to FSK (D) was not different from that seen
in the presence of luminal Cl− (Fig. 2). ∗∗∗P < 0.001, ∗P < 0.05; ns, no statistical difference; n = 5–9.
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secretion in vivo and in vitro (Clarke et al. 2001; Furukawa
et al. 2004; Singh et al. 2010). Preincubation of duodenal
and mid-colonic mucosa with 20μM of the NHE3
inhibitor S1611 completely abolished the FSK-induced
J HCO −3 in CFTR KO mucosa, and reduced it in WT and
F508del mucosa. The absolute magnitude of decrease was
similar in all genotypes (Fig. 7A and B).
Can F508del-CFTR-enhanced HCO3− secretion be
influenced by CFTR inhibitors?
We next tested whether HCO3− secretion in F508del
mutant intestine is sensitive to CFTR inhibitors. Figure 7A
and B displays forskolin-induced J HCO −3 in WT, F508del
and CFTR KO duodenal and mid-colonic mucosa
without inhibitors (left bars), after NHE3 inhibition
with 20μM S1611 (middle bars), and after addition of
the CFTR inhibitors CFTRinh-172 and GlyH-101 to the
luminal bath in the continued presence of S1611 (right
bars). Any residual FSK-induced J HCO −3 in CFTR KO
mucosa was abolished by S1611 (Fig. 7A and B, middle
bars). Moreover, any residual S1611-insensitive J HCO −3
in F508del duodenal, WT mid-colonic and F508del
mid-colonicmucosawas abolished by theCFTR inhibitors
(Fig. 7A and B, right bars). Since the CFTR inhibitors had
little effect on basal J HCO −3 (even in colonicmucosa, where
the high J HCO −3 rates are largely Cl
−/HCO3− exchange
mediated), these results suggest that the CFTR inhibitors
act predominantly by preventing F508del-CFTR acting as
a Cl− recycling pathway for Cl−/HCO3− exchange. To also
test this hypothesis in vivo, we compared the FSK-induced
Figure 6. Luminal Cl− removal abolished the augmentation of FSK-induced J HCO −3 by F508del CFTR
membrane expression in mid-colonic mucosa
Replacement of Cl− in the luminal bath by gluconate caused a strong decrease in the basal JHCO −3
in each
genotype (A), and reduced the JHCO −3
in the F508del mucosa to the JHCO −3
values seen in the CFTR KO
mucosa (A and C). Basal Isc (B) and Rt (E) increased significantly in all three genotypes, and the Isc response
to FSK (D) was significantly lower in WT and F508del mucosa compared to that in the in the presence of luminal
Cl− (Fig. 3). ∗∗P < 0.01, ∗P < 0.05; ns, no statistical difference; n = 5–9.
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J HCO −3 in the colon of anaesthetized F508del mice in
the presence of CFTR inhibitors with that seen in the
CFTR KO colon (of note, S1611 cannot be used in
the in vivo experiments). The CFTR inhibitors reduced
the magnitude of FSK-induced J HCO −3 in F508del
colon to that seen in CFTR KO colon (Fig. 8). These
data suggest that the augmented FSK-induced HCO3−
secretory response in F508del compared to CFTR KO
intestine may be dependent on the channel activity of the
mutant protein. The interpretation of these experiments
is complicated by the fact that CFTRinh-172 andGlyH-101
are not completely specific for CFTR (Steward et al. 2011,
Figure 7. FSK-induced J HCO −3
is reduced by NHE3 inhibition
and abolished by pharmacological inhibition of CFTR in
F508del duodenal and colonic mucosa
Isolated duodenal (A) and mid-colonic (B) mucosa were preincubated
with S1611 (20 μM) (middle column) or with S1611 plus the CFTR
inhibitors CFTRinh-172 (20 μM) and GlyH-101 (10 μM) (right column).
In the duodenal mucosa, S1611 preincubation alone reduced the
effect of FSK on JHCO −3
by approximately 25–35% in WT and
F508del mucosa, and completely inhibited JHCO −3
in the CFTR KO
mucosa (A, middle column). The CFTR inhibitors decreased the
S1611-insensitive FSK-induced JHCO −3
by about 40% in the
WT, and abolished JHCO −3
in the F508del mucosa (A, right
column). Qualitative similar findings were obtained in the mid-colon
(B). This demonstrates that F508del-CFTR channel activity is required
for the FSK-induced Cl−/HCO3− exchange in F508del mucosa. ns,
no statistical difference; ∗P < 0.05 vs. CFTR KO (duodenum or
mid-colon) without inhibitors, #P < 0.01 vs. WT duodenum without
inhibitors, §P < 0.01 vs. F508del duodenum without inhibitors,
†P < 0.05 vs. WT mid-colon without inhibitors, ‡P < 0.05 vs.
F508del mid-colon without inhibitors; n = 3–5.
Caputo et al. 2008; Kelly et al. 2010), nor do they fully pre-
vent CFTR activation in intact WT intestine (see suppl.
Fig. 2, and De Boeck et al. 2011).
Forskolin and luminal Cl− removal induced OSR1 and
SPAK phosphorylation in intestinal mucosa in vivo
One puzzling finding of this study is the fact that luminal
Cl− removal had no inhibitory effect on FSK-induced
J HCO −3 inWTmucosa, but inhibitedJ HCO −3 in F508del
mucosa. Because this result suggests a high HCO3−
permeability of CFTR in WT intestine, we investigated
whether luminal Cl− removal or FSK addition activates
the WNK downstream kinases OSR1 and SPAK in vivo.
Western blot analysis of protein lysate from scraped
duodenal mucosa after in vivo perfusion with hypo-
tonic Cl−-free solution, performed with an antibody
against the phosphorylated T-loop of OSR1 and SPAK,
demonstrated time-dependent phosphorylation of OSR1
and SPAK (Fig. 9A), indicating that this signal pathway is
activated in murine duodenum in vivo. We next assessed
whether FSK activates SPAK/OSR1. This was indeed the
case (Fig. 9B), suggesting that the lack of dependence of
FSK-induced J HCO −3 on luminal Cl
− in WT intestine
may be explained by strong SPAK/OSR1 phosphorylation
during FSK stimulation.
Figure 8. Pharmacological inhibition of CFTR abolished the
augmentation of FSK-induced J HCO −3
by F508del CFTR
membrane expression in the colon of anaesthetized mice
in vivo
Luminal application of CFTRinh-172 (20 μM) and GlyH-101 (10 μM)
reduced the FSK-induced JHCO −3
in F508del perfused mid-colon
(black and shaded bars) of anaesthetized mice to the level seen in
the CFTR KO colon (open bar). The FSK-induced JHCO −3
in the
CFTR KO colon is due to FSK-induced NHE3 inhibition; however, a
sequential application of all inhibitors, as was done in Fig. 7 in
isolated mucosa, is not feasible in vivo. ∗P < 0.05; ns, no statistical
difference; n = 3–5.
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Finally, we assessed whether there was a difference
in SPAK/OSR1 phosphorylation in WT, F508del and
CFTR KO duodenum. While both FSK and luminal
Cl− free perfusion quickly increased the amount of
phosphorylated OSR1 and SPAK in WT duodenum,
CFTR KO mucosa displayed levels of phosphorylated
SPAK/OSR1 far below those seen in WT mucosa under
control conditions (Fig. 9B–D). Interestingly, a significant
increase in phospho-SPAK/OSR1 was also seen in F508del
duodenum in response to FSK or luminal Cl− free
perfusion (Fig. 9B–D). These data suggest that the low
levels of Cl− conductance provided by apical membrane
expression of F508del-CFTR are sufficient to restore
WNK-signalling to F508del duodenal mucosa.
Discussion
In 1994, Poulsen et al. reported HCO3− permeability of
CFTR in patch-clamp experiments (Poulsen et al. 1994),
and similar observations were subsequently made by
others (Reddy & Quinton, 2003; Tang et al. 2009). What
about HCO3− transport in CFTR mutants? Some data
suggest a selective loss of the CFTR HCO3− conductance
in disease-causing CFTR mutants that are associated with
more severe CF phenotypes (Choi et al. 2001, Reddy &
Quinton, 2003) or idiopathic pancreatitis (Schneider &
Saur, 2011).Other patch-clamp studies of heterogeneously
expressed CFTR mutants associated with severe CF
phenotypes found both reduced Cl− and reduced HCO3−
permeabilities, but no change in their relationship (Tang
et al. 2009). The most frequent CF mutation, F508del, has
not been studied in this regard. It was therefore unknown
whether F508del, when expressed at the apical plasma
membrane, can mediate both Cl− and HCO3− secretion.
In order to answer this question, we made use of
F508del mice on the FVB/N background, which express
a small amount of mature fully glycosylated CFTR
in the brush border membrane of the small intestine
(French et al. 1996). We bred these mice in parallel
Figure 9. Rescue of defective WNK signalling in F508del duodenum
A and B, SPAK/OSR1 phosphorylation was observed in response to luminal perfusion with Cl− free hypotonic
solution (A), luminal Cl− removal and FSK stimulation in WT duodenum in vivo (B). Each lane represents total
protein lysate from scraped proximal duodenum after in vivo luminal perfusion of one mouse with the indicated
perfusate. B, representative blot of three different experiments. C and D, summary of three experiments in
individual mice of the different genotypes under the indicated experimental conditions. Values were normalised to
β-actin levels. There was significant stimulation of SPAK/OSR1 phosphorylation in WT and F508del, but not CFTR
KO mice. The significance was calculated by ANOVA post hoc test. ∗P ≤ 0.05 and ∗∗P ≤ 0.01; ns, no statistical
difference.
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with CFTR KO mice on the same congenic FVB/N
background, and found approximately 5–10% of WT
band C levels in highly enriched small intestine BBM
from F508del mice. Interestingly, F508del duodenum and
mid-colon, the two segments that are characterized by
the highest HCO3− secretory rates in mouse intestine,
both displayed significantly higher FSK-induced HCO3−
secretory responses compared to CFTR KO mucosa,
despite this small amount of mature CFTR protein in the
apical membrane, and despite a rather low FSK-induced
I sc response. This suggests that even low expression of
mature fully glycosylated F508del CFTR mutant protein
in the apical membrane enabled the intestinal epithelium
to secrete substantial amounts of HCO3− ions.
Our next step was to obtain some insight into
the molecular mechanism for this F508del-augmented
HCO3− secretory response. Based on the literature,
three potential mechanisms are feasible: first, the
activated F508del-CFTR conductance is selective for
HCO3− over Cl−. Such a phenomenon has recently
been reported for WT CFTR in pancreatic duct cells
following activation of the WNK signalling pathway by
low intracellular Cl− concentrations (Park et al. 2010).
We therefore studied whether FSK activated the WNK
signalling pathway in murine intestine by measuring the
phosphorylation of the WNK1/4 downstream kinases
SPAK and OSR1. We observed a strong induction of
SPAK/OSR1 phosphorylation by luminal FSK application
in murine intestine in vivo (Fig. 9). FSK activated the
WNK signalling pathway to a similar degree to long-term
removal of luminalCl−, whichmaywell be the explanation
for the lack of inhibition of agonist-activated HCO3−
secretion by luminal Cl− removal, observed in this paper
as well as other studies, and in different epithelia and
species (Ishiguro et al. 1996, Chan et al. 1996, Guba et al.
1996, Spiegel et al. 2003, Ishiguro et al. 2009). However,
we found no significant difference between SPAK/OSR1
phosphorylation inWTandF508del intestine, while SPAK
phosphorylation was significantly impaired in CFTR KO
intestine. This suggests that WNK signalling, with all
the resultant effects on transepithelial Cl− transport,
is operative in epithelia that express F508del in their
apical membranes. However, because the same strong
SPAK/OSR1 phosphorylation was seen in WT intestine,
the findings were not sufficient to explain the relatively
strong enhancement of FSK-induced HCO3− secretion in
F508del compared toCFTRKO intestine, despite the small
amount ofmembrane-resident channel protein in F508del
compared with WT intestinal mucosa.
A second possible explanation is that the low amount
of F508del CFTR mutant protein stimulates luminal
Cl−/HCO3− anion exchangers, either by direct molecular
interaction or by providing an apical shunt (recycling)
pathway for Cl−. We therefore replaced Cl− in the
luminal bath with the impermeant anion gluconate. This
manoeuvre did not significantly inhibit FSK-induced
HCO3− secretion in theWTmucosa, but reducedJ HCO −3
to the level seen in the complete absence of CFTR
(which was found to be due to FSK inhibition of NHE3,
see Fig. 7). This feature was also observed in colonic
mucosa. This suggests that FSK stimulates a robust
Cl−-independent HCO3− conductance in WT intestine,
whereas the F508del-enhanced HCO3− secretion occurs
predominantly via Cl−/HCO3− exchange (despite robust
SPAK/OSR1 phosphorylation). The critical finding of this
study is, therefore, that the major HCO3− exit pathways
appear to differ in WT and F508del murine intestine, at
least when this assumption is based on results obtained by
the classic manoeuvre of Cl− removal from the luminal
bath.
What may be the reason for an enhanced FSK-induced
apical Cl−/HCO3− exchange in F508del compared to
CFTR KO mucosa? There are three potential reasons for
this finding. First, F508del expression, with the residual
apical Cl− conductance, may result in better overall tissue
integrity, including better Slc26 expression levels. Similar
expression levels for Slc26a6 and Slc26a3 have previously
been demonstrated in CFTR KO and WT intestine by
ourselves and others (Simpson et al. 2005; Tuo et al. 2006),
making it unlikely that differences would exist between
F508del andCFTRKO intestine.Nevertheless,we carefully
studied tissue morphology in the duodenum and colon of
all three genotypes. Although fine differences in villous
length and thickness, crypt depth and lamina propria cell
density were seen, a blinded investigator (U.S.) was unable
to classify histological specimens into the groups ‘KO,
F508del and WT’. This suggests that under our breeding
conditions, chronic intestinal changes appear late in the
life of F508del and KO mice; such mice were not studied
in the present project.
A second potential explanation is that expression
of CFTR, even in mutant form, may enhance the
expression and/or membrane trafficking of apical anion
exchangers irrespective of CFTR channel function. Such
an observation has been made in pancreatic cell lines,
where heterologous expression of CFTR influenced the
expression and/or activity of endogenous Cl−/HCO3−
exchangers independent of CFTR channel function
(Ignath et al. 2009). We therefore tested whether the
relatively specific CFTR inhibitors CFTRinh-172 (Ma et al.
2002) and GlyH-101 (Muanprasat et al. 2004) inhibited
duodenal and colonic HCO3− secretion to a higher degree
in F508del compared to CFTR KO mucosa. Indeed,
luminalCFTRinh-172 andGlyH-101 applicationdecreased
FSK-induced HCO3− secretory rates in F508del mucosa
to the rates observed in CFTR KO mice. Since the effects
of these agents on basal HCO3− secretory rates (which
are strongly dependent on apical Cl−/HCO3− exchange,
particularly in the mid-distal colon (Xiao et al. 2012),
were not significant, we assume that this inhibitory effect
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may be more related to CFTR channel inhibition than
to (direct) Slc26 anion exchange inhibition. However,
interference with other pathways cannot be fully ruled
out.
A third concept that best explains our findings is that
Cl− recycling at the apical membrane, as a means to
activate luminal Cl−/HCO3− exchange, requires CFTR
channel function (Greger et al. 2001; Simpson et al. 2005;
Singh et al. 2010). One may speculate that Cl− exit via
CFTR, coupled to Cl− uptake in exchange for HCO3− exit
via an electroneutral Cl−/HCO3− exchanger, results an
equivalent rise in I sc to that of the titrated HCO3− in the
luminal bath. However, the apical Cl−/HCO3− exchangers
in the intestine may, in part, be electrogenic (Chernova
et al. 2005; Lamprecht et al. 2005, 2006; Ohana et al.
2009; Yamaguchi et al. 2009; Alper et al. 2011). Other
conductances are also activated by FSK (Sørensen et al.
2010), and the time courses of the I sc andHCO3− secretory
responses may be different due to technical reasons. Thus,
FSK-induced I sc and J HCO −3 need not be numerically
identical for Cl− recycling to explain enhanced intestinal
epithelial HCO3− secretion. In addition, the activation
of an apical anion conductance (i.e. membrane-resident
F508del) may affect membrane potential, cell volume and
pHi; these events in turn may affect apical and basolateral
HCO3− transporters and result in an overall increase in
epithelial HCO3− secretion.
What may explain the observation that the magnitude
of FSK-mediatedJ HCO −3 was not significantly influenced
by the absence of luminal Cl− in WTmucosa, while it was
reduced to levels seen in CFTR KO intestine in F508del
mucosa? Our working hypothesis was that inWTmucosa,
theFSK-inducedactivationof apical anion effluxviaCFTR
may cause cell shrinkage and a decrease in [Cl−]i (Valverde
et al. 1993; MacLeod et al. 1994; Bachmann et al. 2003;
Gawenis et al. 2004), which in turnmay activate theWNK
signalling pathway, resulting in the phosphorylation of the
downstream kinases OSR1 and SPAK (Kahle et al. 2005;
Park et al. 2010), and a change of the anion selectivity of
CFTR from Cl− to HCO3− selectivity (Park et al. 2010).
This would explain the Cl−-independent stimulation of
J HCO −3 in WT mucosa, which we observed. To explain the
dependence of FSK-mediated J HCO −3 on luminal Cl
− in
F508del mucosa, we further speculated that differences
in WNK signalling may occur between WT and F508del
intestine, because we anticipated that the shrinkage and
loss of [Cl−]i in F508del (and CFTR KO) epithelial cells
would be insufficient to activate the WNK signalling
pathway. However, this was not found to be the case for
F508del mucosa, in which SPAK/OSR1 phosphorylation
upon either FSK addition or luminal Cl− removal was
similar to WT, whereas it was significantly attenuated in
CFTR KO mucosa.
Despite substantial SPAK/OSR1 phosphorylation in
F508del intestine, FSK-stimulated HCO3− secretion was
nevertheless dependent on luminal Cl− and thus likely to
a large part be mediated by Cl−/HCO3− exchange. This
does not preclude a HCO3− permeability of F508del itself
upon WNK activation, which may have simply been too
small to detect, and which may become apparent when
pharmacological strategies to deliver more F508del to
the membrane become available. It also suggests to us
that in WT intestine, luminal Cl−/HCO3− exchange is
inhibited by FSK, not so much because of SPAK/OSR1
phosphorylation, but by the largeCFTR-mediatedHCO3−
conductance (which is high, both because the channel
is strongly expressed in the membrane and because
SPAK/OSR1 is phosphorylated). High CFTR-mediated
HCO3− conductance would reduce the driving force
for HCO3− efflux via Cl−/HCO3− exchange. However,
in F508del intestine, this CFTR-mediated HCO3−
conductance is low (because of the small amount of
F508del-CFTR protein in the membrane, irrespective of
SPAK/OSR1 phosphorylation) and may not be sufficient
to result in inhibition of HCO3− efflux via Cl−/HCO3−
exchange. On the contrary, apical Cl−/HCO3− exchange
maybecomeactivatedbyCl− effluxviamembrane resident
F508del to provide the increased HCO3− efflux. Evidence
in support of this hypothesis, although not firm proof, is
a rapid decrease in pHi in microdissected duodenal villi
after FSK application (Y. Qin, unpublished observations).
What may be the clinical significance of this finding?
Species differences have been reported in the processing
and membrane expression of F508del-CFTR, with
better stability in murine than human epithelial cells
(Ostedgaard et al. 2007). Thus, the use of amurine F508del
model provided us with an epithelium with residual
F508del-CFTR membrane expression even without the
use of pharmacological agents to deliver more F508del to
the plasma membrane. The better survival of the F508del
mice with less organ pathology and fewer obstructive
episodes has already been demonstrated (French et al.
1996, Wilke et al. 2011) and it stands to reason that
this might be linked to the markedly higher intestinal
alkalinization rates found in this study. The transporter(s)
for this F508del-augmented alkalinization are most likely
not predominantly the mutated CFTR, but Slc26a3 and
possibly other members of this anion exchanger gene
family. If a similar situation exists in CF patients, with
F508del-CFTRmembrane expression in intestinalmucosa
either spontaneously (van Barneveld et al. 2010) or
after successful treatment with pharmacological agents
(Lukacs&Verkman, 2012), knowledge about the transport
properties of these anion exchangersmay be important for
clinicians when they treat intestinal complications of CF
patients.
In summary, we have shown that expression of even
small amounts of F508del-CFTR in the brush border
membrane significantly enhances the forskolin-induced
HCO3− secretory response in both murine duodenum
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and colon compared to CFTR KO mice. This secretion
of HCO3− is dependent on luminal Cl− in both
intestinal segments and therefore likely due toCl−/HCO3−
exchange. In addition, the expression of F508del-CFTR
partially restores WNK signalling, which is defective in
CFTR-deficient intestine. Small molecules that prevent
proteasome degradation of F508del-CFTR, resulting in
more mutant protein reaching the apical membrane,
may therefore have the potential to significantly enhance
intestinal HCO3− secretion, improve mucus viscosity and
prevent intestinal impactions.
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